Jean-Olivier Racine - May 10, 2024 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role: Chief Technology Officer
Signature: By: John L Brottem For: Jean-Olivier Racine
Stock symbol: OM
Transactions as of: May 10, 2024
Transactions value $: -$27,161
Form type: 4
Date filed: 5/10/2024, 06:19 PM
Previous filing: Feb 16, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OM	Common Stock	Sale	-$27.2K	-8.31K	-3.04%	$3.27	265K	May 10, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).

Content

Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting on May 10, 2024, of an aggregate of 33,923 shares of Common Stock underlying RSUs granted to the reporting person on June 22, 2021, January 26, 2022 and January 6, 2023, which were subject to accelerated vesting approved by the Compensation Committee of the Board in connection with the reporting person's departure. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Includes 1,801 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2023 to February 29, 2024. This transaction is exempt from Rule 16b-3(c).